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1. Introduction 
Amyotrophic lateral sclerosis (ALS), also called Lou Gehrig's disease, is a rapidly progressive 
neuromuscular disease that attacks the neurons responsible for controlling voluntary 
muscles. It belongs to a group of disorders known as Motor neuron diseases (MND): all these 
syndromes share a common molecular and cellular pathology comprising degeneration of 
motor neurons (MNs) in cortex, brainstem and/or spinal cord, and the presence of 
characteristic ubiquitin and TDP-43-immunoreactive intraneuronal inclusions. 
ALS prevalence in Western countries ranges from 2.7 to 7.4 per 100,000 (Worms, 2001). In 90 
to 95 percent of all patients with ALS (PALS), the disease occurs sporadically (sporadic ALS, 
sALS); in 5 to 10 percent there is a family history of ALS (familial ALS, fALS). Most people 
developing ALS are between the ages of 40 and 70 years (Haverkamp et al., 1995). The 
disease is 20% more common in men than in women, although more recent data suggest 
that the gender ratio may be approaching equality (Logroscino et al., 2008). 
The cause of ALS is not known, and it is not clear why ALS strikes some people and not 
others, but both genetic (Ticozzi et al., 2011) and environmental factors (Callaghan et al., 
2011; Calvo et al., 2010; Ferrante et al., 1997) may play a role. 
In PALS, both the brain upper MNs (UMNs) and the brainstem or spinal cord lower MNs 
(LMNs) degenerate or die: unable to function, the muscles gradually weaken, waste away, 
and twitch, leading to a wide range of disabilities. Patients lose their strength and the ability 
to move their body, but usually maintain control of eye muscles. 
Approximately 70% of PALS have a spinal form of the disease: they present with symptoms 
which may start either distally or proximally in the upper or lower limbs. Some patients see 
the effects of the disease on a hand or arm, as they experience difficulty with simple tasks 
requiring manual dexterity, such as buttoning a shirt, writing, or turning a key in a lock; in 
other cases, symptoms initially affect one of the legs, and patients experience awkwardness 
when walking or running, or they notice that they are tripping or stumbling more often. 
Patients with bulbar-onset ALS usually present with dysarthria leading to slow slurred 
speech or a nasal quality; they may also develop dysphagia for solid or liquids after noticing 
speech problems; almost all patients with bulbar symptoms complain of sialorrhoea with 
excessive drooling due to difficulty of swallowing saliva and UMN-type facial weakness, 
which affects the lower part of the face, causing difficulty with lip seal and blowing cheeks. 
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The gag reflex is preserved and often brisk, whereas the soft palate may be weak; patients 
show wasting and fasciculations of the tongue which moves slowly, also due to muscle 
hypertonia. The other cranial nerves remain intact, although in late stages of the disease 
patients may very rarely develop a supranuclear gaze palsy or oculomotor palsy (Kobayashi 
et al., 1999; Okuda et al., 1992). 
2. Communication issues in ALS patients 
Five functional domains have to be taken into account when communication is concerned: a) 
motivation to interact; b) cognitive skills (particularly - but not exclusively - those related to 
language); c) visual and auditory capacities; d) ability to utter sounds and words; and e) 
writing skills. As a matter of fact, affective disorders, anxiety and emotional discomfort, as 
well as cognitive impairment or sensory deficits, can compromise communication processes, 
by interfering directly and/or indirectly with speech and writing performances. 
However, ALS does not usually either affect a person’s ability to see, smell, taste, hear, or 
recognize touch; nor impair mind or intelligence - although a small percentage of patients 
may experience problems with memory or decision-making (Raaphorst et al., 2010; Ringholz 
et al., 2005), and there is growing evidence that some may even develop a form of dementia 
(Guedj et al., 2007). On the other hand, since the disease usually does not affect cognitive 
abilities, PALS are aware of their progressive loss of function and may become anxious and 
depressed (Patten et al., 2007). 
The vast majority of PALS experience a motor speech disorder as the disease progresses: 
since ALS involves both UMNs and LMNs, it results in mixed dysarthria of the flaccid-spastic 
type characterized by effortful, slow productions with short phrases, inappropriate pauses, 
imprecise consonants, hypernasality, strain-strangled voice, as well as decreased pitch and 
loudness range (Duffy, 1995; Tomik & Guiloff, 2010). 
In the early stages when dysarthria is mild, either spasticity or flaccidity is predominant: 
initial symptoms typically do not interfere with speech intelligibility and may be limited to a 
reduction in speaking rate, a change in phonatory quality, or imprecise articulation (Ball et 
al., 2004a; Nishio & Niimi, 2000; Yorkston et al., 1993; Yunusova et al., 2010). 
Features of spasmodic dysphonia (or focal laryngeal dystonia) may also occur in PALS, 
sometimes as the initial clinical symptom (Roth et al., 1996). Typically, laryngeal structure is 
normal in appearance. When corticobulbar involvement prevails (spastic forms), there is often 
a pattern of hyperadduction of the vocal mechanism, and when bulbar involvement 
dominates (flaccid forms), there is usually a pattern of hypoadduction. 
As disease progresses and dysarthria becomes severe, profound weakness resulting in 
reduced movement of the speech musculature and severe hypophonia become increasingly 
common (Yunusova et al., 2010). 
Perceptual and acoustic features of dysarthria in ALS have been well studied (Tomik & 
Guiloff, 2010): the decrease in rate is often associated with increased pause time and 
enhanced segment durations, particularly for vowel sounds (Green et al., 2004; Tjaden & 
Turner, 2000; Turner & Weismer, 1993); spectral vowel and consonant properties (e.g., 
formant frequencies, transition extents and slopes) are also affected, with vowels becoming 
more centralized and the consonant frequency spectrum less distinct (Kent et al., 1989, 1992; 
Tjaden & Turner, 1997; Turner et al., 1995; Weismer et al., 1988, 1992, 2001). 
Such acoustic findings have been presumed to be due to the disease-related reduction and 
slowing of articulatory movements (Weismer et al., 1992). Articulatory findings, although 
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limited, support such an interpretation. An early study on articulatory kinematics in two 
PALS showed slowed articulatory movements, reduced displacement of the tongue and lip, 
together with exaggerated displacements of the jaw during diadokokinetic tasks (Hirose et 
al., 1982). A more recent study of articulatory movements in a group of 9 PALS reported an 
impairment of articulatory speed during vowels (Yunusova et al., 2008): aberrant 
displacements were found to be word- and vowel-dependent and were more consistently 
present in movements of the tongue than in those of other articulators, and occasionally in 
the jaw; the jaw displacements were smaller than normal in words requiring larger 
articulator movements (e.g., consonant plus low vowel), but were larger than normal in 
words that only required relatively small jaw movements (e.g., consonant plus high vowel), 
suggesting difficulty in scaling of the vowel-related movements. 
Whereas initially, along a gradual slowing of speaking rate, speech intelligibility remains 
relatively high, it decreases overtime, when dysarthria becomes more and more apparent to 
PALS themselves and their listeners. Yorkston and co-workers (1993) suggested that speech 
intelligibility may vary across dysarthric patients depending on the subsystems that are 
preserved (e.g., relatively less impaired respiratory-phonatory subsystem and the jaw might 
be associated with better speech intelligibility); the rate of disease progression; and the 
patient’s cognitive status. 
Because a person’s ability to communicate orally is typically assessed based on speech 
intelligibility, anticipating the decline in intelligibility in a sensitive way is critical for timely 
clinical management of bulbar PALS. In this regard, longitudinal studies are, indeed, 
necessary when the goal of research is to identify early predictors of future changes; 
additionally, longitudinal studies are advantageous when dealing with heterogeneous 
populations, as in the case of PALS, since each patient can serve as his own control. 
Investigations of such a type documented the decline in speech intelligibility and speaking 
rate (Kent et al., 1992; Mulligan et al, 1994; Nishio & Niimi, 2000; Yorkston et al., 1993); and 
some studies have also identified several acoustic-based speech markers of disease 
progression (Mulligan et al., 1994; Ramig et al., 1990). 
In their retrospective study of more than a hundred clinical cases, Yorkston and co-workers 
(1993) reported that speaking rate was a reliable predictor of speech intelligibility decline, by 
observing a rapid deterioration in speech intelligibility shortly after a decline in speaking 
rate to 100-120 words per minute. Such a finding was replicated by Ball and co-workers 
(2002) in a large group of patients with bulbar symptoms of different severity: the authors 
suggested that speaking rate decline to 100-120 words per minute should serve as a clinical 
indicator for beginning to support communication by assistive technology. 
Moreover, since ALS progresses so rapidly in many subjects, an important goal of clinical 
management is to anticipate functional changes in patients’ performance in order to teach 
new communication strategies and compensatory skills before the patient’s ability to learn 
these skills is impacted by the severity of their condition. Recently, Yunusova and co-
workers (2010) in a longitudinal study on 3 PALS tested the feasibility of using kinematic 
measures as early predictors of intelligibility decline, trying to understand the relationship 
between physiologic changes in speech movements and clinical measures of speech 
performance (such as speaking rate and speech intelligibility). Lip and jaw movements were 
quantified with respect to their size, speed, and duration.  
Results showed that, differently from oral strength measures, changes in lip and jaw 
movements were related to ALS progression: in two out of 3 PALS, the changes in measures 
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of path distance and speed anticipated the drop in speech intelligibility by approximately 3 
months, whereas speaking rate decline was more gradual; and increases in movement 
duration overtime closely mimicked the pattern of speech intelligibility decline. Overall, the 
kinematic measures seemed to be sensitive to disease progression: they might therefore be 
useful clinical markers for initiation of compensatory interventions. 
Parallelly to decline in speech intelligibility, communication effectiveness is reduced at first in 
adverse speaking situations, such as noisy crowds, and then in all situations. Ball and co-
workers (2004b) reported that perceptions of communication effectiveness for PALS were 
quite similar to those of their frequent listeners (spouse or family member) across 10 
different social situations: a range of communication effectiveness was reported depending 
upon the adversity of specific social situations. 
Significant dysarthria can lead to frustration on the part of the patient when others are 
unwilling to spend the time to carefully listen. Friends and healthcare workers may not listen 
to the patient; there is a temptation to anticipate answers and finish sentences for the patient. 
Fatally, at some point in their disease progression, 80 to 95% of PALS are unable to meet 
their daily communication needs using their natural speech, and finally most become unable 
to speak at all. 
Moreover, upper limb paralysis prevents them from using hands in writing (directly or 
through computer-linked keyboards or communication devices). 
Ultimately, in the so-called “locked-in” cases, a diffuse somatic immobility takes them away 
any possibility to interact with the world, except by using eye movements - even more 
unfortunately lost in those PALS classified as having a “super locked-in” syndrome, who 
may rely only upon their brain electrical waves as a communication tool processed through 
complex brain-computer interface (BCI) devices. 
3. Functional assessment 
Many assessments have been proposed for patient’s follow-up in order to analyze the state 
of motor function and their consequences on activities of everyday life (Couratier et al., 
2006). Clinimetric scales must be validated and relatively simple to use, and generate 
ordinate results allowing statistical analysis: global scales - Norris Scale (Norris et al., 1974), 
Appel ALS Rating Scale (Appel et al., 1987), ALS Severity Scale (Hillel et al., 1989), and ALS 
Functional Rating Scale (ALSFRS) (Cedarbaum & Stambler, 1997) - can be employed to 
evaluate disability progression. 
By using, for instance, ALSFRS - or its revised version, ALSFRSR (Cedarbaum et al., 1999) - , 
communication impairment can be assessed through scores on speech function together 
with those related to handwriting, since people communicate by speaking and/or writing: 
scores < 2 in both speech and handwriting items correspond to a substantial inability to 
communicate. 
Dysarthric speech can be evaluated through the Frenchay Dysarthria Assessment (Enderby & 
Palmer, 2008) originally developed by Pamela Enderby in 1983, which represents a well-
established clinical tool to quantitatively evaluate the organs involved in speech and 
provides a measurement of intelligibility.  
Complete kit includes examiner’s manual, 25 rating forms, and intelligibility cards: patient 
is rated on a number of simple performance tasks related to speech function.  
Intelligibility can be measured also through another test developed by Yorkston and co-
workers: the Assessment of Intelligibility of Dysarthric Speech (Yorkston et al., 1984), a tool for 
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quantifying single-word intelligibility, sentence intelligibility, and speaking rate of adult 
and adolescent speakers with dysarthria. Standard protocols containing speaker tasks, 
recording techniques, and listener response formats are employed to obtain a variety of 
intelligibility and communication efficiency measures. 
Yorkston and co-workers (1993) initially suggested that PALS speaking rate reduction precedes 
decreases in intelligibility; Ball and co-workers (2001, 2002) reported that speaking rate on the 
Speech Intelligibility Test - Sentence Subtest (Yorkston et al., 2007) is a relatively good predictor of 
PALS intelligibility deterioration. This computerized test supports the efficient measurement of 
speaking rate in clinical settings; it helps patients and their families monitor changes over time, 
and reinforces their understanding of speaking rate and intelligibility. Using this test, speaking 
rate can also be accurately monitored over the telephone if a patient lives at a distance, or is 
unable to travel (Ball et al., 2005a): it should be noted, anyway, that speech intelligibility could 
not be objectively assessed over the telephone, as a clinical measure of understandability. 
The vocal impairment can be difficult to assess because the voice disorder in dysarthria often 
occurs along with other impairments affecting articulation, resonance, and respiration: an 
effective assessment tool is the Multi-Dimensional Voice Program, a multi-parameter acoustic 
analysis (Kent et al., 2003). 
4. Treatment 
Differently from an acute, self-limited disease with expected recovery, the choice of 
appropriate therapeutic options for PALS raises more difficult concerns, since one must take 
into account many personal and ethical considerations. Several decisions by PALS and their 
families regarding treatment hinge on their concept of the quality of life that will result from 
such treatments. 
At the present time, ALS therapy can be organized under the following multiple modalities: 
a pathogenetic treatment – to counteract MN degeneration; and a symptomatic treatment – 
to reduce impairments in motor abilities including those involved in communication. The 
appropriate implementation of each one of these types of therapy reflects the difficulties that 
we now have to face in ALS treatment. Supportive care is best provided by 
multidisciplinary teams of health care professionals, such as physicians; physical, 
occupational, and speech therapists; nutritionists; social workers; and home care and 
hospice nurses (Bede et al., 2011): working with patients and caregivers, these teams can 
design an individualized plan of medical and physical therapy and provide special 
equipment aimed at keeping patients as “functional” as possible. 
Taking now into account such a symptomatic approach, two kinds of therapeutic strategies 
have to be implemented, those using drugs and those employing assistive/rehabilitative 
methods and techniques, aids and devices. 
4.1 Pharmacological strategies 
Physicians can prescribe medications to ameliorate fatigue, ease muscle cramps, control 
spasticity, and reduce excess saliva and phlegm; drugs also are available to help patients 
with pain, depression, anxiety, and sleep disturbances (Bede et al., 2011; Gordon, 2011; 
Guidubaldi et al., 2011; Guy et al., 2011; Miller et al., 1999; 2009a,b). 
It is almost obvious that a patient experiencing less fatigue, pain, anxiety and depression, 
and controlling better saliva and spasticity, also apart from specific speech and writing 
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motor deficits (which, indeed, are improved by reduced sialorrhoea and muscle hypertonia), 
will be able to successfully manage his/her language impairment, being more committed to 
communicate and keep social contacts. 
4.2 Non pharmacological strategies 
The primary goal of an effective assistive rehabilitation for PALS is the management of 
disabilities, symptoms and complications arising from the progressive weakness of limb, 
trunk, and bulbar muscles. Further goals include keeping the patient functioning as 
independently as possible, and maintaining quality of life even into the terminal stage 
(Francis et al., 1999). 
The rehabilitation program varies depending on whether the patient has a long clinical 
course or rapid progression of the disease: in the former case, PALS become able to 
compensate remarkably well for the motor unit loss and are able to continue with their daily 
activity for several years (Chen et al., 2008). The success of the rehabilitation approach 
depends on the active participation of the patient who should be a full partner in the 
therapeutic team even during the advanced stages of the disease. It may be difficult for the 
physician to discuss such a fatal illness: however, a direct approach allows the patient to 
deal most effectively with the disease and its physical limitations. This also helps in 
decisions about the intensity of the therapeutic effort (Bede et al., 2011; Gordon, 2011). 
The family and other caregivers should be encouraged to participate in the patient’s early 
rehabilitation program: the family role will then likely increase as weakness progresses, 
requirements for assistive devices change, and new problems arise in the management of 
activities of daily living. 
4.2.1 Treatment of impaired communication 
Loss of effective communication prevents patients from participating in many activities; 
may lead them to social isolation; and reduces their quality of life: the goal of clinical 
management of dysarthric PALS is to optimize communication effectiveness for as long as 
possible. Communication solutions, which may include no-technology, low-technology and 
high-technology options will be discussed, as well as the importance of psychosocial issues 
and the factors influencing the use of these systems. 
Dysarthric PALS may benefit from working with a speech therapist: these health professionals 
can teach patients adaptive strategies, such as techniques to help them speak louder and 
more clearly. In early disease stages, patients can be taught to emphasize certain syllables 
and slow their speech patterns so that others can understand them better: lip and tongue 
exercises can sometimes help the patient to enunciate words more clearly on a regular basis. 
A recent review on ALS communication research (Hanson et al., 2011) concluded that, due 
to ALS pathophysiology and the intrinsic degenerative nature of disease, speech treatment 
strategies designed to increase strength or mobility of the oral musculature are not 
recommended for PALS. Patients or their caregivers, on the contrary, often request oral 
exercises to improve strength and mobility for speech, as strengthening exercises seem 
intuitively to them as a way to increase performance: however, such exercise programs 
should be discouraged, and PALS should be informed that the speaking that they do each 
day provides a sufficient amount of speech mechanism activity and exercise. 
Speech intervention should focus on learning to conserve energy for priority speaking tasks 
and to rest often to reduce fatigue, instead of increasing effort with speech exercises. PALS 
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speakers should learn to avoid adverse speaking/listening situations by muting the 
television, inviting people to speak with them in a quiet place rather than in a crowded 
room, and using voice amplification when speaking in noisy environments to reduce the 
effort required (Ball et al., 2007; Yorkston et al., 2010).  
On the basis of a retrospective study on 25 dysarthric PALS treated with a palatal lift and/or 
augmentation prosthesis, the use of such devices should be regarded as effective in 
improving speech: 84% of patients treated with a palatal lift reported reduction of 
hypernasality (76% benefiting, at least moderately, for 6 months), and 60 % of those treated 
with a combination of palatal lift and augmentation prosthesis demonstrated improvement 
in articulation (Esposito et al., 2000). 
Writing may be used as a substitute for speech, and devices as simple as paper and pencil, 
alphabet cards, portable typewriter, and letter boards may be utilized by patients with 
adequate hand function. Becoming speech more and more difficult to understand, many 
PALS supplement their speech by identifying the first letter of each word on an alphabet 
board (alphabet supplementation), or by identifying the topic on a communication board (topic 
supplementation). 
As ALS progresses, speech therapists can help patients develop ways for responding to 
yes-or-no questions with their eyes or by other nonverbal means, and can recommend 
aids such as speech synthesizers and computer-based communication systems: these 
methods and devices help patients communicate when they can no longer speak or 
produce vocal sounds. 
The technological revolution has expanded communication options for PALS who cannot 
rely on natural speech and writing. The assistive technologies are categorized as 
Augmentative and Alternative Communication (AAC) devices. Four critical features need to be 
considered within clinical and research domains: language representation, output mode, 
motor access, and microprocessor units. 
Language representation has got remarkable attention for speaking rate enhancement. 
Whereas most PALS spell and rely on typing as a form of input, they can never approach 
speech production rates: often the slowness of AAC devices reduces their utility. Nowadays 
devices are being designed that integrate natural language processing and prediction 
algorithms for word, utterance and even conversational level units as one tries to approach 
natural speaking rates. 
The output mode has seen advances for the storage of digitized voice as well as qualitative 
improvements to synthetic speech. 
Voice banking is often considered as an early treatment option: PALS with intact motor 
speech skills store their spoken sounds, words, sentences for future use in customized 
communication devices. The personalized voice and messages can be used along with 
standard text-to-speech output to retain the PALS’ voice signature: engineering efforts to 
customize synthetic speech to the user’s own voice through minimal speech sampling are 
going on. Scientists and technicians are pursuing the gold standard for a device: bad speech 
in and good speech out, with attention being paid to recognition of dysarthric speech and 
production of personalized voices. 
Motor access problems are being addressed with visual evoked potentials, detection of 
alpha and theta waves, and eye gaze recognizers so that head, shoulders, knees and toes are 
no longer needed: most devices now offer a range of access methods, starting with 
keyboards, touch screens, a head mouse, and Morse code. 
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Finally, microprocessor units are available in every shape and size to meet user needs, from 
palmtops to laptops made of magnesium-alloy shells, to software that can be downloaded 
from the Internet and accessed through any home computer. 
AAC has a remarkable importance in dysarthric PALS management. When a person has a 
severe verbal communication impairment, AAC can meet the overall goals of palliative care: 
AAC can improve quality of life by optimizing function, assisting with decision making, 
and providing opportunities for personal growth. 
Clinical decision-making related to communication is quite complex as screening, referral, 
assessment, acquisition of technology, and training must occur in a timely manner, so that 
when residual speech is no longer effective, AAC strategies are in place to support 
communication related to personal care, healthcare, social interaction, community 
involvement. Many reports of use and frequency for the purposes of staying connected and 
discussing important issues point out that AAC technology can assist the patient-caregiver 
dyad in maintaining previous relationships. The face-to-face spontaneous conversation 
mode is used most frequently, despite the slow rate of production, the lack of permanence, 
and the demands on conversational partners during message generation (Fried-Oken et al., 
2006). 
PALS, their family members, and, at times, their medical team, usually do not wish to 
consider an AAC decision until the deteriorating speech intelligibility limits the 
communication effectiveness: unfortunately, once intelligibility begins to decrease, speech 
performance often deteriorates so rapidly that there is little time to implement an 
appropriate AAC intervention. Indeed, appropriate timing of referral for AAC assessment 
and intervention continues to be a relevant clinical decision-making issue. The speaking rate 
should be clinically monitored so that the referral for an AAC intervention is initiated in a 
timely manner: Ball and co-workers (2001, 2002) recommend that patients be referred for 
AAC assessment when their speaking rates reach 125 words/min (normal value: 190 
words/min) on the Speech Intelligibility Test - Sentence Subtest) (Yorkston et al., 2007). With 
sufficient education and preparation, PALS and their caregivers are ready to examine their 
AAC options timely: nevertheless, speech deterioration can be so rapid anyway that 
individuals can be left with limited communication options, if they are not really prepared 
to act in an opportune manner. 
Due to the extended AAC use with deteriorating levels of physical control, it is imperative 
that recommended technology has adjustable access options to meet the range of motor 
capability as the disease progresses (s. above). 
PALS should be fitted with AAC technology that supports multiple access methods, such as 
allowing them to transition from hand access to scanning and/or head/eye-tracking. Many 
AAC devices now incorporate a variety of access options so that the technology can 
continue to meet the needs of the user despite a decline in physical capability: the sensitivity 
of dynamic touch screens can be adjusted to allow for lighter touch; the improved sensitivity 
of head-tracking technology has allowed many patients to use this access method with 
minimal head/neck movement control. 
Perhaps the most significant advancement in access technology has occurred with the 
widespread availability of eye-tracking systems to allow cursor control with eye movement to 
access high-technology AAC devices. As the disease progresses, many PALS require the use 
of eye-tracking for several reasons. Firstly, compared to other access methods (such as 
switch-activated scanning), eye-tracking is often reported to be the least fatiguing method 
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(Gibbons & Beneteau, 2010) and its technology requires relatively little effort (Calvo et al., 
2008; Harris & Goren, 2009): eye gaze is natural, and eye muscles generally do not fatigue 
with use. Secondly, eye gaze may be the only volitional movement that the individual 
continues to exhibit over time, particularly in cases where invasive ventilation has been 
chosen (Ball et al., 2010). 
BCI technology has generated considerable interest for people who are physically “locked-
in”, such as PALS in the late stages of the disease. BCI devices translate into computer 
commands volitional modulation of brain signals which can be recorded from the scalp 
using electroencephalography (EEG) or magnetoencephalography; from the dura mater or 
cortical surface using electrocorticography; or from neurons within the cortex. 
A common signal for BCI is the P300 event-related potential, a positive deflection in the EEG 
over parietal cortex, that occurs approximately 300 ms after an “oddball” stimulus: a rare 
but meaningful stimulus among a series of frequently occurring stimuli. Since the P300 
occurs among other ongoing EEG activity, several P300 responses must usually be averaged 
for the response to be recognized (Polich, 2007). Farwell and Donchin (1988) introduced the 
first P300-based BCI paradigm: computer presents a 6×6 matrix of letters and commands on-
screen and participants attend to the item they wish to select; groups of matrix items are 
flashed randomly: only flashes of groups containing the attended item should elicit a P300. 
Items are grouped for flashing as rows and columns: hence, the so-called “row-column 
paradigm” (RCP). The computer identifies the attended item as the intersection of the row 
and column that elicited the largest P300. 
The RCP has been tested in various configurations to achieve efficient communication that is 
practical for in-home use (Krusienski et al., 2006; Lenhardt et al., 2008; Sellers et al., 2006); 
the paradigm itself has been modified (Guger et al., 2009; Hong et al., 2009; Martens et al., 
2009; Salvaris & Sepulveda, 2009; Takano et al., 2009). Unfortunately, none of such 
alternative paradigms substantially improves P300-based BCI performance. The RCP 
remains subject to errors that slow communication, cause frustration and diminish 
attentional resources (Vaughan et al., 2006). Further RCP research could possibly help 
severely disabled BCI users, who desire speed, accuracy, and ease of use. Moreover, with 
the RCP, some people are not able to achieve accuracy high enough for practical BCI use 
(Sellers & Donchin, 2006). 
In recognition of these issues, Townsend and co-workers (2010) sought to create an 
alternative stimulation paradigm that could be faster, more accurate and more reliable than 
the RCP: they designed the so-called “checkerboard paradigm” (CBP), using a standard 8×9 
matrix of alphanumeric characters and keyboard commands. In the RCP, the 8 columns and 
9 rows flash at random: in contrast, in the CBP, the standard matrix is virtually 
superimposed on a checkerboard which the subjects never actually see. The items in white 
cells of the standard matrix are segregated into a white 6×6 matrix and the items in the black 
cells are segregated into a black 6×6 matrix; before each sequence of flashes, the items 
randomly populate the white or black matrix, respectively. The end result is that the subjects 
see random groups of 6 items flashing (as opposed to rows and columns), because the 
virtual rows and columns flash. In other words, the standard matrix never changes: only the 
pattern of flashing items is changed. After all rows and columns in both matrices have 
flashed (i.e., 24 flashes, comprising one complete sequence), the program re-randomizes the 
positions of the items in each virtual matrix and the next sequence of flashes begins 
(Townsend et al., 2010). The CBP produced a significant increase in BCI performance and 
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user acceptability over the RCP, thus providing a substantially more effective BCI, which is 
so important for PALS management. Experimental data showed that, whereas average 
PALS performances were much lower than those of the healthy controls using the RCP, 
upon switching to the CBP, PALS performed only slightly lower than the healthy controls: 
patients improved their classification accuracy rates by an average of about 25 % after 
switching from the RCP to the CBP, whereas accuracy rates of control group improved only 
of 14 %, thus suggesting that the CBP improvements may be more pronounced for PALS 
than for healthy controls. In particular, for two patients, the improvement brought them into 
an accuracy range sufficient for effective BCI control, while previously their accuracy was 
not consistently enough for effective control. 
Non-invasive BCI methods have been utilized more extensively than invasive methods for 
people with disabilities (Birbaumer & Cohen, 2007; Birbaumer et al., 2008; Gerven et al., 
2009): unfortunately, whereas PALS and other patients in “locked-in” conditions have 
motivated research in this area, very few systems have been successfully used - such as 
that reported by Townsend and co-workers (2010). It has been postulated that some forms 
of cognitive impairment and changes in EEG signatures in late ALS stages may contribute 
to the lack of success using BCI technology (Iversen et al., 2008), as the technology was 
introduced after the participants had become “locked-in” (Gerven et al., 2009; Münte et 
al., 1998): really, the most successful application for communication has occurred in 
people at the beginning stages of ALS (Birbaumer et al., 1999; Birbaumer, 2006; Kubler et 
al., 2001). 
Nowadays, AAC acceptance and use represent two areas of interest for physicians and 
scientists. Both involve PALS and their caregivers. 
In the Ball et al.’s review (2004b), those who rejected AAC had a co-occurring cognitive 
deficit or experienced a severe diseases, such as cancer, in addition to ALS. 
Fried-Oken and co-workers (2006) reported very positive caregivers’ attitudes toward AAC 
technology: those with greater AAC technology skills got greater rewards associated with 
caregiving. 
In a follow-up study on 15 PALS, Ball and co-workers (2010) examined the acceptance, 
training, and extended use patterns of eye-tracking technology to support communication. 
For 53% of the participants, eye-tracking technology was selected because eye movement 
was the only viable access option available. More than 90% of the participants reported 
successful implementation of the technology: the only one patient who was not able to 
successfully use eye-tracking technology had difficulty with eyelid control. The 
communicative functions served by eye-tracking devices were extensive: all of the 
participants used their device to support face-to-face communication, and other functions 
included group communication, phone, e-mail and internet. More than 40% of the 
participants also reported using the eye-tracking technology to support other computer-
based functions (e.g., word processing, voice-related software programs). 
Training and support are an essential component of AAC service delivery for PALS. The 
significant changes in movement abilities require that service providers not only be 
proactive in their AAC technology recommendations by fitting up technology options that 
can meet the changing physical needs over time, but also by supplying adequate training 
and support to ensure that PALS and their caregivers can successfully implement 
diachronically these access strategies. Reports of low AAC use often are related to 
descriptions of minimal training or follow-up (Murphy, 2004). 
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New advances in AAC technology may need a greater amount of training and intervention 
than other access options: for instance, implementation of eye-tracking systems often 
requires for successful technology use trouble-shooting in the form of physical or 
environmental compensations (Ball et al., 2010). Whereas AAC specialists are professionals 
who provide the AAC intervention services (such as assessment and initial instruction), 
AAC facilitators for PALS tend to be family members who typically provide ongoing 
support (including instruction of new communication partners and caregivers, 
programming new messages into the AAC device, maintaining the AAC system, and 
interacting with the technology manufacturer, if necessary) (Beukelman et al., 2008). 
In a survey on 68 PALS using AAC technology Ball and co-workers (2005b) studied the AAC 
facilitators: almost all of them were family members, the majority with nontechnical 
backgrounds. They reported to prefer hands-on and detailed step-by-step instruction; and to 
have received an appropriate training amount (slightly over 2 hours of instruction). 
5. Conclusion 
Multifunctional impairments of PALS result from a relentlessly progressive muscle 
weakness, leading ultimately to a widespread body paralysis. In the late disease stages, 
patients eventually find themselves in a “locked-in” state, totally unable to move neck, 
trunk and limbs; autonomously breath and feed; and speak, although most of them retain 
their cognitive skills, thereby assisting impotent at their dreadful somatic decay. 
As human beings, and therefore “persons”, namely “individuals within a network of 
relationships”, PALS particularly suffer from communication impairment. 
Today, much more than in the past, we are able to give interdisciplinary assistance to them, 
enhancing their possibilities of keeping in touch with their caregivers, friends and other 
persons, with the aim to maintain their quality of life as high as possible. 
Further research is needed to better implement AAC devices and services (trying to 
optimize communication aids and interfaces, and increase our understanding of acceptance 
and use of AAC approaches); and to develop new intervention strategies and document 
their effectiveness. 
Anyway, besides scientific and clinical achievements, we look forward to building up in the 
near future more empathic care strategies for PALS and their families, with respect to them 
in their dignity of suffering persons. 
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